The simple answer is: not easy. Like all people, doctors get used to the products they use and need a compelling reason to change. Especially when it's something as specialised and delicate as a burr hole in the skull. This is in a different league from medication, where the key ingredients in a new product might be similar to existing meds. So we're up against habit and familiarity, two things that are difficult to shift.
On our side is the fact that there are compelling reasons to change to Osteopore products. I base that on the 20,000 successful operations completed using OSX products. From memory (reading the prospectus) not one patient has experienced complications as is often the case with implants and regular bone-regeneration techniques. There's a ton of verifiable data to back this up, as you'd expect with a company making sensitive medical products. Additionally, OSX has been granted approval to sell in the USA, Europe, China (and other Asian countries I can't recall now) and Australia. This in itself is a big deal to garner support from surgeons.
OSX is not a start-up, it's simply a newly listed company. The company was founded 20 years ago and put in many years with zero income to develop their products to the point where they are now known to be safe and effective. That's what surgeons are interested in. So, while it will still take time to encourage them to jump ship, the reasons for doing so are compelling. Once a few influencers make the move, others will follow.
Add to My Watchlist
What is My Watchlist?
